chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had a heart attack. I didn't have any pain in the arm or other symptoms to indicate that I was having a heart attack. The only thing I noticed was while sitting on the bed I couldn't move and I had a heavy feeling in my chest. I just felt really weird. My son took me to the ER. I had a STEMI heart attack. I had 2 stents placed in the coronary arteries. 1 went in the descending aorta, and I'm not for sure where the other one was placed. I had 98% blockage in the descending aorta. I was prescribed an anticoagulant blood thinner. Then after about 2 weeks of starting that medication called Clopidogrel 75mg 1xday I started coughing up blood. Since 12/26/2021. I have also been prescribed Atorvastatin 18mg 2xday, Metoprolol Tartrate 50mg 2xday, and Aspirin 81mg. Since then they have recently added Metformin 500mg 2xday and Losartan 25mg 1xday.
my husband received 4 covid moderna  vaccines 2/26/21  3/24/21 10/29/21 5/20/22 he had covid in 11/2020 Prior to receiving covid vaccine his hct   in 2017 was 48.4 1/2018 43.5 . 8/2018 43.1  10/2020 6/2021 47.6 5/63.2 He was diagnosed with polycythemia vera and is currently being treated for this with monthly bloddletting
Patient found deceased in facility.  Medical Examiner cause of death:  A. Ketoacidosis B. due to COVID-19 vaccination complicating undiagnosed diabetes mellitus.  Contributory: Hypertensive cardiovascular disease.;   Autopsy report was signed on 11/4/2021
Information was received on 11-JUL-2017 from a representative regarding her friend, a 50 year old male patient who did not want his name provided. The patient told the representative yesterday that after getting ZOSTAVAX (lot#/expiration unknown) injection, .65 ml one time, to prevent shingles on 09-JUL-2017, his arm became "big, red and puffy" (onset 09-JUL-2017). Treatment was provided for adverse event; "he put ice on it". Patient's present status is recovering. Patient was given the vaccine by an unspecified health care professional at an unspecified pharmacy. Concomitant medication included "a statin" (not further details provided). No additional adverse event information was provided. Patient refused to provide contact information. Additional information is not expected.
Rash and swelling developed 1 week after injection.  Itching and swelling continued for at least 1 day.
Immediately after administrating the shot, the patient's arm developed a hardening around the injection site. Her skin also had red spots in a circular pattern around the injection site. She said her arm felt heavy.
mild dizziness lasting <1min became more frequent over the course of a few days. Became extremely ill on 01/19/21 nausea, vomiting, unable to eat or drink, constant dizziness, hearing loss and tongue numbness on right side,  unable to get out of bed. Went to ER 1/21/21.  Dizziness has been constant and unchanged since.
This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 06Mar2021 at 17:00 (at the age of 33-years-old) as a single dose for COVID-19 immunization. Medical history included thyroid, pollen allergy and fruit allergy (melon a doctor thinks it pollen but patient had to get tested for pollen allergy). The patient had not received any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since vaccination, the patient had not tested for COVID-19. Concomitant medication included levothyroxine; 50 Milligram (mg) (MANUFACTURER UNKNOWN) form an unknown date for an unknown indication. On 10Mar2021 at 09:00, the patient experienced her period was about a week late, four days after had a mild heat like rash on face and chest but did not last long and get like that when she has melon. The patient had not received any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events late period, heat rash on face and chest was recovered on an unknown data in Jun2021. No follow-up attempts possible. No further information expected.
Diagnosed with breast cancer; This case was reported by a pharmacist via call center representative and described the occurrence of breast cancer in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced breast cancer (serious criteria GSK medically significant). The patient was treated with tamoxifen and non-drug therapy (Radiation Therapy). On an unknown date, the outcome of the breast cancer was unknown.   It was unknown if the reporter considered the breast cancer to be related to Shingrix.  Additional information was received as follows: The patient received the first dose of Shingrix in November 2019, and was diagnosed with breast cancer after receiving dose one and received radiation therapy as a treatment. This patient was starting treatment with tamoxifen and has not received Shingrix dose two as of 23rd April 2020. The reporter did not consented for follow up.
25-MAY-92 severe joint pain in shoulder, knees, groin-joints snap & pop; tired, difficulty sleeping; 30MAY92 pain; r/o arthritis; D added muscle relaxant which helps greatly but pt remains tired & shoulders hurt when lifting items;
No adverse event; Pediatric dose was given to adults mistakenly; Moderna COVID-19 vaccine administered to patient post temperature excursion; Moderna COVID-19 vaccine administered to patient post temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patient post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered to patient post temperature excursion) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2022, the patient experienced WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patient post temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered to patient post temperature excursion). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patient post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered to patient post temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patient post temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered to patient post temperature excursion).    This case contains information for the 68th of 104 adult patients described by the reporter. Concomitant product use was not provided by the reporter. It was reported there was a temperature excursion between 26-May-2022 to 30-Sep-2022 and lot AR5186C was affected between 08-Sep-2022 to 27-Sep-2022. AR5186C was previously reported. Pediatric dose was given to adults mistakenly and were reported to CDPH, VAERS, CAIR and each patient that received the error dose, with instructions to re-vaccinate 2 months from the initial error dose. 051B22A was kept in the freezer upon receipt of shipment on 01-Aug-2022 and individual vials were put in the refrigerator on the day of use.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-669791 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-669791:
This spontaneous report as received from a mother of the patient refers to a 15 month old female patient who was at present 5 year old. No medical history and concurrent conditions were reported. On an unknown date approximately in 2011 when the patient was 15 month old, the patient was vaccinated with M-M-R II, 1 single shot. No concomitant therapy was reported. On an unknown date approximately in 2011, she developed a fever of 102 degrees and 4 hour later she had a seizure (medically significant). She had another seizure (medically significant) 3 months later on an unspecified date approximately in 2011. The outcome of both seizures and fever was unknown. The causality assessment was not given. Patient sought medical attention and spoke with physician. Product quality complaint was not reported. Upon internal review the event of seizure was considered medically significant. Additional information is not expected as reporter did not wish to provide specific information.
Swelling and redness at site. Hard and hot to touch. Reaction occurred less than 24 hrs. after injection.
I developed left forehead and scalp pain  associated with a rash-shingles.  I did seek care with my PCP and was treated.
Information has been received from a health professional concerning a 6 yr old white female with no known medical history or allergies who on 27Dec99 was vaccinated in the right thigh with a first dose of varicella virus vaccine live (lot630408/0293J). Concomitant vaccination that day included a third dose of hep B vaccine, recomb (Engerix B) (lot ENG2356A2) in the right thigh and a fourth dose of Hib conj vaccine (lot03585S) in the left thigh. On 21Aug05 the child developed a rash all over her body. She was brought into the office on 22Aug05. She was diagnosed with chickenpox. Treatment consisted of diphenhydramine hydrochloride (Benadryl), oatmeal baths and calamine lotion prn. The pt recovered within one week. No lab diagnostic tests were performed. There was no product quality complaint involved. Additional information is not expected.
Lymph nodes on both sides swollen and hurting; Lymph nodes on both sides swollen and hurting; After third dose had swelling 3-4 hours later; Low grade fever, arm was itching like crazy, glands swollen; Low grade fever, arm was itching like crazy, glands swollen; This spontaneous case was reported by a pharmacist and describes the occurrence of LYMPHADENOPATHY (Lymph nodes on both sides swollen and hurting), LYMPH NODE PAIN (Lymph nodes on both sides swollen and hurting), VACCINATION SITE SWELLING (After third dose had swelling 3-4 hours later), PYREXIA (Low grade fever, arm was itching like crazy, glands swollen) and VACCINATION SITE PRURITUS (Low grade fever, arm was itching like crazy, glands swollen) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 091D21A, 030L20A and 023M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PRAVASTATIN and LAMOTRIGINE (LAMICTAL) for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Lymph nodes on both sides swollen and hurting), LYMPH NODE PAIN (Lymph nodes on both sides swollen and hurting), VACCINATION SITE SWELLING (After third dose had swelling 3-4 hours later), PYREXIA (Low grade fever, arm was itching like crazy, glands swollen) and VACCINATION SITE PRURITUS (Low grade fever, arm was itching like crazy, glands swollen). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, LYMPHADENOPATHY (Lymph nodes on both sides swollen and hurting), LYMPH NODE PAIN (Lymph nodes on both sides swollen and hurting), VACCINATION SITE SWELLING (After third dose had swelling 3-4 hours later), PYREXIA (Low grade fever, arm was itching like crazy, glands swollen) and VACCINATION SITE PRURITUS (Low grade fever, arm was itching like crazy, glands swollen) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-356141, MOD-2021-356142 (Patient Link).
About 38 hours after shot, red patches/welches appeared in chest and upper back and have slowly gotten worse. As of today, 11/20, red welts are spreading to hairline and trunk and down back. Now he is saying they feel like they are ?burning?.
This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 09-SEP-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # of L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion were 24, 108 and 192 hours and the lowest recorded temperature reported were 33, 34 and 32 Fahrenheit (F) (0.555555556, 1.111111111 and 0 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator (R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor Quality Product Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
rash on upper left arm; hardness(injection site); swelling (injection site); sore arm; Patient believes injection was administered too quickly; felt so much pressure; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION COMPLICATION (Patient believes injection was administered too quickly; felt so much pressure), RASH (rash on upper left arm), VACCINATION SITE INDURATION (hardness(injection site)) and VACCINATION SITE SWELLING (swelling (injection site)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION COMPLICATION (Patient believes injection was administered too quickly; felt so much pressure). On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 10-Mar-2021, the patient experienced RASH (rash on upper left arm), VACCINATION SITE INDURATION (hardness(injection site)) and VACCINATION SITE SWELLING (swelling (injection site)). On 01-Mar-2021, VACCINATION COMPLICATION (Patient believes injection was administered too quickly; felt so much pressure) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm), RASH (rash on upper left arm), VACCINATION SITE INDURATION (hardness(injection site)) and VACCINATION SITE SWELLING (swelling (injection site)) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2021: Reporter details provided, vaccine details provided, event outcome (ongoing) provided
EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a pharmacist concerned a 22 year old male. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1820095 expiry: 04-JUL-2021) dose was not reported, administered on 13-MAY-2021 10:00 for prophylactic vaccination. No concomitant medications were reported. On 13-MAY-2021, the subject experienced expired vaccine administered. The action taken with covid-19 vaccine  was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious.
Patient was administered Moderna COVID-19 vaccine past the expiration date / Administered expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered Moderna COVID-19 vaccine past the expiration date / Administered expired vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered Moderna COVID-19 vaccine past the expiration date / Administered expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered Moderna COVID-19 vaccine past the expiration date / Administered expired vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by reporter.  Age of the patient was reported as over 50 years and the 4th dose (2nd booster) of the patient was administered on 02 April 2022. Manufacturing date of the vaccine was 01 Dec 2021. Date the vial was initially stored in the refrigerator 24 Mar 2022 3:05 PM. The vial did not undergo any temperature excursions.  No treatment medication reported by reporter.   This case was linked to MOD-2022-532061 (Patient Link).
3 days after vaccination and continuing, lightheaded numbness and shortness of breath. Went to ER on 8 Aug and doctors could not find anything wrong With me. Left and 10 minutes later numbness from head to toe, lightheaded and shortness of breath. The day after 9 august, woke up with chills and shortness of breath, was taken to ER. Doctors could not find a life threatening issue. On 14 Aug went to ER with significant chest pain. Doctors once again could not find anything life threatening even though the pain seems to be coming from my heart. The only thing I can explain it to be was the Jansen vaccine reaction.
Patient had facial swelling - especially eyes, hives, and wheezing/respiratory distress 25 min after shot. Pt had eaten pecans 30 min prior but has no food allergy. Pt had a sat of 92%. BENADRYL, steroids and albuterol were given.
This 79 year old female received the Covid shot on 2/19/21    and went to the ED and admitted on  4/22/21     with the following diagnoses listed below. I21.4 - Non-ST elevation (NSTEMI) myocardial infarction
Lt arm red, swollen, itchy, uncomfortable after vaccination. Saw MD & prescribed KEFLEX. Mother says arm looked fine by 9-2-11.
Erythema in the site Left leg along with vesicles. MMR given 3 days before in the same leg. Prednisone 15/5, 1 tsp daily for 5 days given. Mom reports rash better.
Patient received second dose on 24Apr2021, over 90 days after 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second dose on 24Apr2021, over 90 days after 1st dose) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second dose on 24Apr2021, over 90 days after 1st dose). On 24-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second dose on 24Apr2021, over 90 days after 1st dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatments were provided.
skin rash transversing neck, chest and stomach area. Slighly itchy.  Took 25 mg of benadryl.  Onset about 50 hours post vaccine.  Fever and chills present day prior and morning of.  Of note:  dose 1 and 2 were Pfizer and rash occured
Arm swollen till elbow, rash on upper body, lump on the site. High fever 101.7 ok on 11/24/2008 arm yellow. Taking NAPROXEN and BENADRYL,  for PNEUMOVAX.
Lymph node swelling on the side where vaccine was received (left).  Lymph nodes enlargement approximately the size of tennis ball.  Extreme fatigue.  Swelling eventually subsided after 2 weeks.
Rash - at forehead, chest and back for 2 days. Vaccinations were 13 days ago. No fever. Treatment: isolation, symptomatic treatment, advise.
Severe flu-like symptoms, fever, vomiting, rash. resolved after 24 hours.
woke up 8/28/21 with face swollen, right eye almost swollen shut, and hives scattered on rest of body  also got flu shot at same time as booster shot - didn't realize I needed to add to item 4 and can't go back on screen
As per mother, pt had fever, headaches, vomiting after HPV #2 vaccine was adminastered.
I'm having a lot of body pain and my legs and arms; weakness; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (I'm having a lot of body pain and my legs and arms), ASTHENIA (weakness), MYALGIA (body aches) and PYREXIA (fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (I'm having a lot of body pain and my legs and arms), ASTHENIA (weakness), MYALGIA (body aches) and PYREXIA (fever). At the time of the report, PAIN IN EXTREMITY (I'm having a lot of body pain and my legs and arms), ASTHENIA (weakness), MYALGIA (body aches) and PYREXIA (fever) had resolved.            The concomitant medications were not reported.  The treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Significant follow up appended outcome of event was updated